Cargando…

Narrating the natural history of live infection by SARS CoV-2 VOC in animal models

Detalles Bibliográficos
Autor principal:	Altmann, Daniel M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631722/ https://www.ncbi.nlm.nih.gov/pubmed/34861489 http://dx.doi.org/10.1016/j.ebiom.2021.103704

Ejemplares similares

Convergent evolution of SARS-CoV-2 in human and animals
por: Zhou, Hang-Yu, et al.
Publicado: (2021)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

Are Animals a Neglected Transmission Route of SARS-CoV-2?
por: Hernández, Marta, et al.
Publicado: (2020)

The ins and outs of SARS-CoV-2 variants of concern (VOCs)
por: Salehi-Vaziri, Mostafa, et al.
Publicado: (2022)

Natural History of Asymptomatic SARS-CoV-2 Infection
por: Sakurai, Aki, et al.
Publicado: (2020)

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data
por: Díaz, Natalia A., et al.
Publicado: (2021)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

SARS-CoV-2 Delta VOC in a Paucisymptomatic Dog, Italy
por: Pascucci, Ilaria, et al.
Publicado: (2022)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

Abrupt decreases in infectivity of SARS-CoV-2 in aerosols
por: Löndahl, Jakob, et al.
Publicado: (2022)

SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface
por: Sharun, Khan, et al.
Publicado: (2021)

Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden
por: Strålin, Kristoffer, et al.
Publicado: (2021)

Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
por: Thye, Angel Yun-Kuan, et al.
Publicado: (2021)

Acute kidney injury in SARS-CoV-2 infected patients
por: Fanelli, Vito, et al.
Publicado: (2020)

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
por: Machhi, Jatin, et al.
Publicado: (2020)

Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B.1.1.7 in Pakistan through international travelers
por: Nasir, Asghar, et al.
Publicado: (2022)

Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
por: Meekins, David A., et al.
Publicado: (2021)

Consulting the Oracle of SARS-CoV-2 Infection
por: Lemieux, Jacob E, et al.
Publicado: (2021)

Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection
por: Zeng, Yong, et al.
Publicado: (2020)

SARS-CoV-2 and the testis: similarity with other viruses and routes of infection
por: Cardona Maya, Walter D., et al.
Publicado: (2020)

“The ancient and the new”: is there an interaction between cytomegalovirus and SARS-CoV-2 infection?
por: Moss, Paul
Publicado: (2020)

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
por: Goudsmit, Jaap
Publicado: (2020)

Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
por: Samet, Jonathan M
Publicado: (2020)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

When is the SARS-CoV-2 infection over and what is post-COVID?
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses
por: van der Hoek, Lia
Publicado: (2020)

Alpha variant SARS-CoV-2 infection: How it all starts
por: Domingo, Pere, et al.
Publicado: (2021)

Molecular insights into onset of autoimmunity in SARS‐CoV‐2 infected patients
por: Laxminarayana, Dama
Publicado: (2022)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Analysis of Host Cell Receptor GRP78 for Potential Natural Reservoirs of SARS-CoV-2
por: Sirakov, I., et al.
Publicado: (2020)

SARS-CoV-2 Susceptibility of Domestic Animals and Wildlife in the Media Narrative
por: Di Guardo, Giovanni
Publicado: (2022)

Adaptive immunity to SARS-CoV-2
por: Altmann, Daniel M
Publicado: (2020)

Epidemiological dynamics of SARS-CoV-2 VOC Gamma in Rio de Janeiro, Brazil
por: Moreira, Filipe Romero Rebello, et al.
Publicado: (2021)

Analysis of the Transmission of SARS-CoV-2 Delta VOC in Yantai, China, August 2021
por: Sun, Yulou, et al.
Publicado: (2022)

Natural history of SARS-CoV-2 infection in healthcare workers in Northern Italy
por: Bongiovanni, M., et al.
Publicado: (2020)

Dilemmas for Natural Living Concepts of Zoo Animal Welfare
por: Learmonth, Mark James
Publicado: (2019)

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
por: Bekliz, Meriem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l2mm8u6eek30r2mq7pd2vjh4tc